These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 33666709)
1. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach. Gonzalez-Jimenez A; Suzuki A; Chen M; Ashby K; Alvarez-Alvarez I; Andrade RJ; Lucena MI Arch Toxicol; 2021 May; 95(5):1793-1803. PubMed ID: 33666709 [TBL] [Abstract][Full Text] [Related]
2. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs. Hong H; Thakkar S; Chen M; Tong W Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches. Zhao Y; Zhang Z; Kong X; Wang K; Wang Y; Jia J; Li H; Tian S Chem Biol Drug Des; 2024 Aug; 104(2):e14607. PubMed ID: 39179521 [TBL] [Abstract][Full Text] [Related]
9. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study. Wang MG; Wu SQ; Zhang MM; He JQ Front Immunol; 2022; 13():1002126. PubMed ID: 36483548 [TBL] [Abstract][Full Text] [Related]
10. AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules. Rao M; Nassiri V; Alhambra C; Snoeys J; Van Goethem F; Irrechukwu O; Aleo MD; Geys H; Mitra K; Will Y Chem Res Toxicol; 2023 Jul; 36(7):1129-1139. PubMed ID: 37294641 [TBL] [Abstract][Full Text] [Related]
11. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital. Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873 [TBL] [Abstract][Full Text] [Related]
12. Current challenges and controversies in drug-induced liver injury. Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150 [TBL] [Abstract][Full Text] [Related]
13. Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury. Moore R; Ashby K; Liao TJ; Chen M Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682349 [TBL] [Abstract][Full Text] [Related]
14. Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints. Liu X; Zheng D; Zhong Y; Xia Z; Luo H; Weng Z Biomed Res Int; 2020; 2020():4795140. PubMed ID: 32509859 [TBL] [Abstract][Full Text] [Related]
15. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury. Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315 [TBL] [Abstract][Full Text] [Related]
17. Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury. Wu L; Liu Z; Auerbach S; Huang R; Chen M; McEuen K; Xu J; Fang H; Tong W J Chem Inf Model; 2017 Apr; 57(4):1000-1006. PubMed ID: 28350954 [TBL] [Abstract][Full Text] [Related]
18. Development of a Battery of Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological features in 138 cases of drug-induced liver injury]. Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136 [TBL] [Abstract][Full Text] [Related]
20. Drug-induced liver injury and drug development: industry perspective. Regev A Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]